3
Announcements
Trials
Browse
Landscape
Status
Completed
88
Recruiting
39
Terminated
18
Unknown
14
Active not recruiting
9
Withdrawn
4
Not yet recruiting
2
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Colorectal Neoplasms
39
Stomach Neoplasms
20
Carcinoma, Hepatocellular
20
Pancreatic Neoplasms
15
Colonic Neoplasms
13
Esophageal Neoplasms
10
Liver Neoplasms
9
Rectal Neoplasms
8
Esophageal Squamous Cell Carcinoma
8
Cholangiocarcinoma
8
Breast Neoplasms
8
Barrett Esophagus
8
Carcinoma, Non-Small-Cell Lung
6
Neoplasms
5
Postoperative Complications
4
Liver Cirrhosis
4
Gastrointestinal Neoplasms
4
Gallbladder Neoplasms
4
Diabetes Mellitus
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Lymphatic Metastasis
3
Lung Neoplasms
3
Fibrosis
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Anastomotic Leak
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Kidney Neoplasms
×
Gastrointestinal
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled